|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Medications and Drugs), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Medications and Drugs
Categories
|
Pharmaceuticals ... |
Statins ... |
Medications and Drugs News
MedicineNet Medications General
Title: OTC Pain Relievers and Fever Reducers
Category: Medications
Created: 9/21/1999 8:31:00 PM
Last Editorial Review: 2/11/2010
Category: Medications
Created: 9/21/1999 8:31:00 PM
Last Editorial Review: 2/11/2010
MedicineNet Medications General
Title: maraviroc, Selzentry
Category: Medications
Created: 2/5/2010 3:21:00 PM
Last Editorial Review: 2/5/2010 3:21:48 PM
Category: Medications
Created: 2/5/2010 3:21:00 PM
Last Editorial Review: 2/5/2010 3:21:48 PM
MedicineNet Medications General
Title: darunavir, TMC-114; Prezista
Category: Medications
Created: 2/5/2010 3:03:00 PM
Last Editorial Review: 2/5/2010 3:03:34 PM
Category: Medications
Created: 2/5/2010 3:03:00 PM
Last Editorial Review: 2/5/2010 3:03:34 PM
MedicineNet Medications General
Title: raltegravir, Isentress
Category: Medications
Created: 2/5/2010 2:42:00 PM
Last Editorial Review: 2/5/2010 2:42:24 PM
Category: Medications
Created: 2/5/2010 2:42:00 PM
Last Editorial Review: 2/5/2010 2:42:24 PM
MedicineNet Medications General
Title: etravirine, Intelence
Category: Medications
Created: 2/5/2010 2:35:00 PM
Last Editorial Review: 2/5/2010 2:35:42 PM
Category: Medications
Created: 2/5/2010 2:35:00 PM
Last Editorial Review: 2/5/2010 2:35:42 PM
MedicineNet Medications General
Title: enfuvirtide, T-20; Fuzeon
Category: Medications
Created: 2/5/2010 2:22:00 PM
Last Editorial Review: 2/5/2010 2:22:24 PM
Category: Medications
Created: 2/5/2010 2:22:00 PM
Last Editorial Review: 2/5/2010 2:22:24 PM
MedicineNet Medications General
Title: tipranavir, Aptivus
Category: Medications
Created: 2/5/2010 1:40:00 PM
Last Editorial Review: 2/5/2010 1:40:48 PM
Category: Medications
Created: 2/5/2010 1:40:00 PM
Last Editorial Review: 2/5/2010 1:40:48 PM
MedicineNet Medications General
Title: Gardasil (HPV Vaccine)
Category: Medications
Created: 8/21/2008
Last Editorial Review: 1/25/2010
Category: Medications
Created: 8/21/2008
Last Editorial Review: 1/25/2010
MedicineNet Medications General
Title: Angiotensin II Receptor Blockers (ARBs)
Category: Medications
Created: 4/19/2001
Last Editorial Review: 1/19/2010
Category: Medications
Created: 4/19/2001
Last Editorial Review: 1/19/2010
MedicineNet Medications General
Title: esomeprazole, Nexium
Category: Medications
Created: 5/8/2001 9:07:00 PM
Last Editorial Review: 1/7/2010
Category: Medications
Created: 5/8/2001 9:07:00 PM
Last Editorial Review: 1/7/2010
MedicineNet Medications General
Title: nateglinide, Starlix
Category: Medications
Created: 9/9/2001 12:48:00 PM
Last Editorial Review: 1/7/2010
Category: Medications
Created: 9/9/2001 12:48:00 PM
Last Editorial Review: 1/7/2010
MedicineNet Medications General
Title: ziprasidone, Geodon
Category: Medications
Created: 12/4/2001 6:17:00 PM
Last Editorial Review: 1/7/2010
Category: Medications
Created: 12/4/2001 6:17:00 PM
Last Editorial Review: 1/7/2010
MRSA / Drug Resistance News From Medical News Today
Accelr8 Technology Corporation (NYSE Amex: AXK) announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis...
MRSA / Drug Resistance News From Medical News Today
MicroPhage announced that it has submitted human data from a pivotal clinical study of its 'Microphage MRSA/MSSA Blood Culture Test' to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage's instrument-free, rapid tests is based on the Company's patented Bacteriophage Amplification platform technology...
MRSA / Drug Resistance News From Medical News Today
A University academic who left school early with dreams of being a rock star has been recognised for his internationally outstanding work in microbiology and his studies into the social lifestyle of the opportunistic bacterium Pseudomonas aeruginosa - the leading cause of death in Cystic Fibrosis patients and an important cause of hospital acquired infections...
MRSA / Drug Resistance News From Medical News Today
Acute lymphoblastic leukemia (ALL) most commonly affects children, in whom there is an overall cure rate of 85%. A strong predictor of poor outcome is resistance to chemotherapy with glucocorticoids. Such resistance is caused, at least in part, by an inability of the leukemic cells to die by a process known as mitochondrial apoptosis...
MRSA / Drug Resistance News From Medical News Today
Pfizer Inc (NYSE:PFE) announced that the United States Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) has recommended the use of Prevnar 13? (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) for healthy children aged 2 months through 59 months for the prevention of invasive pneumococcal disease...
MRSA / Drug Resistance News From Medical News Today
The U.S. Food and Drug Administration approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media...
MRSA / Drug Resistance News From Medical News Today
Toxin Does Not Affect MRSA-Induced Pneumonia A group led by Dr. James M. Musser at the Center for Molecular and Translational Human Infectious Diseases Research of The Methodist Hospital Research Institute in Houston, Texas has demonstrated that the cytotoxin Paton-Valentine leukocidin (PVL) does not affect methicillin-resistant Staphlococcus aureus (MRSA)-induced pneumonia...
MRSA / Drug Resistance News From Medical News Today
MRSA Survivors Network, the nonprofit and official organization for World MRSA Day has announced the theme for 2010: "The MRSA Epidemic- A Call to Action...
MRSA / Drug Resistance News From Medical News Today
Investigators at The Methodist Hospital Research Institute in Houston examined for the first time the long-term response to strep throat on a genome-wide level, shedding light on how group A streptococcus interacts with the patient's immune system and attempts to circumvent it. Results were published in the Proceedings of the National Academy of Sciences (PNAS)...
MRSA / Drug Resistance News From Medical News Today
According to a new study, sepsis and pneumonia, two common conditions caused by hospital-aquired infections like MRSA, killed 48,000 Americans in 2006, and cost the nation over 8 billion dollars to treat...
MRSA / Drug Resistance News From Medical News Today
Van Andel Research Institute (VARI) researchers have found a way to reverse resistance to sunitinib, a treatment that is currently the first line of defense against clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer. Most patients who show a positive response to sunitinib develop a resistance to the drug after one year of treatment...
MRSA / Drug Resistance News From Medical News Today
A new paper in the February 17th edition of the journal Molecular Cell describes how exposure to low levels of antibiotics increases mutations in E. coli and Staphylococcus bacteria hundreds of times more than normal, making the creation of drug-resistant strains more likely...
MRSA / Drug Resistance News From Medical News Today
Combining tamoxifen, the world's most prescribed breast cancer agent, with a compound found in the flowering plant feverfew may prevent initial or future resistance to the drug, say researchers at Georgetown Lombardi Comprehensive Cancer Center. The finding, reported online Feb...
MRSA / Drug Resistance News From Medical News Today
Researchers report that they have discovered - and now know how to exploit - an unusual chemical reaction mechanism that allows malaria parasites and many disease-causing bacteria to survive. The research team, from the University of Illinois, also has developed the first potent inhibitor of this chemical reaction. The findings appear in the Proceedings of the National Academy of Sciences...
MRSA / Drug Resistance News From Medical News Today
Multidrug resistant bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) pose a major problem for patients, doctors, and the pharmaceutical industry. To combat such bacteria, it is critical to understand how resistance is developed in the first place...
MRSA / Drug Resistance News From Medical News Today
For years, doctors have warned patients to finish their antibiotic prescriptions or risk a renewed infection by a "superbug" that can mount a more powerful defense against the same drug...
MRSA / Drug Resistance News From Medical News Today
The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria...
MRSA / Drug Resistance News From Medical News Today
A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda "failed quality testing" because of impurities or insufficient amounts of active ingredient, the Associated Press reports. The study, which was conducted by the nongovernmental U.S...
MRSA / Drug Resistance News From Medical News Today
A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS...
MRSA / Drug Resistance News From Medical News Today
A new Queensland Government Fellowship presented today by the Governor of Queensland will be used by a researcher to try to combat an extreme super bug even more aggressive than resistant Staphylococcus strains...
MRSA / Drug Resistance News From Medical News Today
Taxanes, a group of cancer drugs that includes paclitaxel (TaxolŽ) and docetaxel (TaxotereŽ), have become front-line therapy for a variety of metastatic cancers. But as with many chemotherapy agents, resistance can develop, a frequent problem in breast, ovarian, prostate and other cancers...
MRSA / Drug Resistance News From Medical News Today
Researchers at the University of Illinois at Chicago and Israel's Weizman Institute of Science have found that two antibiotics working together might be more effective in fighting pathogenic bacteria than either drug on its own...
MRSA / Drug Resistance News From Medical News Today
An international team of researchers has used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia. The findings shed light on how these deadly bacteria are able to spread from patient to patient in a single hospital and, on a larger scale of geography and time, between countries and entire continents...
MRSA / Drug Resistance News From Medical News Today
"Scientists have found a way to track minutely-differing strains of the 'superbug' MRSA [methicillin-resistant Staphylococcus aureus] as they spread between people and across the globe, a finding that could aid efforts to control the deadly bacteria," Reuters/ABC News reports (Kelland, 1/21)...
MRSA / Drug Resistance News From Medical News Today
Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs...
| ||||||||||||||||||
| ||||||||||||||||||